United Therapeutics (UTHR) Tops Q2 EPS by 22c
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $515.97 +1.47%
Financial Fact:
Cost of product sales: 23.6M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Cost of product sales: 23.6M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q2 EPS of $1.34, $0.22 better than the analyst estimate of $1.12. Revenue for the quarter came in at $225.6 million versus the consensus estimate of $213.33 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Eltek Ltd (ELTK) Reports Q2 EPS of $0.41
- 374Water Inc (SCWO) Misses Q2 EPS by 15c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
